Support First Things by turning your adblocker off or by making a  donation. Thanks!

Geron his issued another press release claiming advances in embryonic stem cell research, and once again saying, as it has for years, that the company is very close to human trials. But that is not the point of this post.

The Geron experiment apparently used rats with damaged hearts. The rats were killed after four weeks, too soon to know whether tumors would form. But get this headline in the Mercury News!

Geron sees progress in stem-cell therapy: STUDY OF HEART ATTACK PATIENTS
The capital letters are within the text.

There was no study of human heart attack patients and the rats weren’t patients, the were “subjects.” I know Ingred Newkirk of PETA believes a rat, is a pig, is a dog, is a boy, but apparently, so do the headline writers at the San Jose Mercury News—at least when it comes to hyping embryonic stem cell research.

Dear Reader,

You have a decision to make: double or nothing.

For this week only, a generous supporter has offered to fully match all new and increased donations to First Things up to $60,000.

In other words, your gift of $50 unlocks $100 for First Things, your gift of $100 unlocks $200, and so on, up to a total of $120,000. But if you don’t give, nothing.

So what will it be, dear reader: double, or nothing?

Make your year-end gift go twice as far for First Things by giving now.
GIVE NOW

Comments are visible to subscribers only. Log in or subscribe to join the conversation.

Tags

Loading...

Filter First Thoughts Posts

Related Articles